this post was submitted on 12 Sep 2023
31 points (100.0% liked)

News

13 readers
2 users here now

Breaking news and current events worldwide.

founded 2 years ago
 

The agency now must decide whether products containing the ingredient, like some Sudafed and NyQuil products, should no longer be sold or perhaps give companies lead time to substitute other ingredients.

you are viewing a single comment's thread
view the rest of the comments
[–] athos77@kbin.social 3 points 2 years ago* (last edited 2 years ago) (2 children)

Does anyone know if phenylephrine is otherwise harmless? If it's essentially harmless, and assuming all these various products have other ingredients that remain effective, then it seems to me that the easiest thing for the companies to do is to move phenylephrine from the "active ingredients" section to the "inactive ingredients" section.

[–] Chetzemoka@kbin.social 3 points 2 years ago

Oh no, phenylephrine definitely has effects. It's just that decongestion isn't one of them. Intravenous phenylephrine is sometimes used in critical care hospital settings to deliberately raise a person's blood pressure:

https://www.lhsc.on.ca/critical-care-trauma-centre/phenylephrine-neosynephrine

load more comments (1 replies)